Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. AAPL
5. NUE
6. ONON
7. AZN
8. SPCX
9. TRMD
10. BCBP

Go back to Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
AbbVie (NYSE: ABBV) Delayed: 265.20 +1.18 (0.45%)
Previous Close $264.02    52 Week High $68.12 
Open $263.29    52 Week Low $50.71 
Day High $266.34    P/E 57.53 
Day Low $262.44    EPS $4.61 
Volume 2,344,949